the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Lateral Flow Technology and the Future of Point of Care Diagnostics

Published by Kalorama Information Contact us : +1-860-674-8796
Published 2007/02 Content info 184 pages
Product code KL48557
Price From  US $ 1995 Order/Price list
US $ 1995 PDF by E-mail (Single User License)
US $ 3395 Hard Copy
US $ 3795 PDF by E-mail (Single User License) & Hard Copy
US $ 3990 PDF by E-mail (Global Site License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

CHAPTER ONE: Executive Summary

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Market Trends

CHAPTER TWO: Introduction

  • Background
  • Rapid Testing in the 21st Century
  • Point of View

CHAPTER THREE: Technical and Marketing Issues in Lateral Flow Device Commercialization

  • The Future for Lateral Flow Patents and Innovation
  • Trends in Nearer the Patient Testing and Decentralization/Central Laboratory Competition
  • The Emergence of Alternate Test Samples
  • The Impact of Microfluidics, Biochips, Particles and Beads
  • The Digital Age- Connectivity
  • Scale-Up and Manufacturing Issues
  • International Markets, Lying in Wait
  • India
  • Latin America
  • Asia
  • Human Genomics- Promise for Molecular- and Cell-Based Disease Assessment

CHAPTER FOUR: Market Analysis

  • Overview
  • LF-POC in World Markets
    • Worldwide
    • United States
    • Europe
    • Japan
    • Government Programs and Private Initiatives
    • United States
    • United Kingdom
    • Continental Europe
    • Asia
    • Privatization
  • The Major Players
  • Market Segments by Setting
    • Self-Test Sector:OTC Tests
    • POL and Clinic Testing
    • POC Testing in the Hospital
    • Home Monitoring of Individuals with Chronic Diseases
  • Market Segments by Testing Area
    • Diabetes- Glucose Control Monitoring
    • Cardiac Markers
    • Drugs of Abuse
    • Infectious Diseases
    • Sepsis
    • Procalcitonin (PCT)
    • Endotoxin
    • Oncology
    • Fecal Occult Blood
    • Prostate Specific Antigen (PSA)
    • Women' s Health, Pregnancy, Fertility
  • Emerging Tests and Technologies
  • Commercial Outlook

CHAPTER FIVE: Company Briefs

  • The Top IVD Companies and Their Lateral Flow Offerings
    • Becton, Dickinson and Company (BD)
    • Beckman Coulter Inc.
    • Biosite Incorporated
    • Instrumentation Laboratory (IL)
    • Inverness Medical Innovations, Inc.
    • Roche Diagnostics
  • The Second Tier and Their Lateral Flow Offerings
    • Access Bio, Inc.
    • Acon Laboratories, Inc./Innovacon
    • Acrongenomics, Inc.
    • Addison-Davis Diagnostics, Inc. (ADDI)
    • ADIATEC
    • Akers Biosciences, Inc.
    • ALFA Scientific Designs, Inc.
    • Amedica Biotech
    • American Bio Medica Corporation
    • Ameritek, USA
    • Amic AB
    • Analyte Works Ltd. (formerly BioPreventative Ltd.)
    • Ani Biotech Oy
    • Asia-Lion Biotechnology Co., Ltd.
    • ASM Scientific Ltd
    • Avitar, Inc.
    • Axis-Shield plc
    • Binax, Inc.
    • bioLytical Laboratories Inc.
    • Biomerica Inc.
    • Biosafe Medical Technologies, Inc.
    • BioScan Screening Systems, Inc.
    • Boditech Med Inc.
    • BRAHMS
    • Branan Medical Corporation
    • Calypte Biomedical Corporation
    • Care Diagnostica International
    • Chembio Diagnostic Systems, Inc.
    • Cholestech Corporation
    • Chongqing Sungene Pharm. Co., Ltd.
    • Cibitest GmbH & Co. KG
    • Cis Biotech, Inc.
    • Coris BioConcept
    • Cozart Bioscience Ltd.
    • Diagenics International Corporation
    • Diagnostic Chemicals Ltd (DCL)
    • Enterix, Inc.
    • ESE Embedded Systems Engineering GmbH
    • EY Laboratories, Inc.
    • Genosis PLC
    • Genzyme Corporation
    • GlysBy snc
    • Grant Life Sciences Inc.
    • Gryphus Diagnostics, LLC
    • Hema Diagnostic Systems, LLC
    • ImmunoScience, Inc.
    • In Veritas Medical Diagnostics (IVMD UK Ltd)
    • IND Diagnostics Inc,
    • Innotrac Diagnostics Oy
    • Instant Technologies, Inc.
    • LifeAssays AB
    • Lifestream Technologies, Inc.
    • MagnaBioSciences LLC
    • Matritech
    • MAVAND Solutions GmbH
    • Medical Services International Inc.
    • Medifix Limited
    • MEDIWISS Analytic GmbH
    • MedMira Inc.
    • Meridian Bioscience, Inc.
    • Milenia Biotec GmbH
    • Mitsubishi Kagaku Iatron, Inc. (MKI)
    • Mossman Associates, Inc.
    • Nano-Ditech Corporation
    • Nanogen Inc.
    • OraSure Technologies, Inc.
    • Panbio Limited
    • Polymedco, Inc.
    • Preventis GmbH
    • Pria Diagnostics LLC
    • Princeton BioMeditech Corporation
    • Proteome Systems Ltd
    • Quidel Corporation
    • r-Biopharm AG
    • Reagena Ltd
    • rennesens GmbH
    • Response Biomedical Corp.
    • Saliva Diagnostic Systems , Inc. (SDS)
    • Savyon Diagnostics
    • Shionogi & Co., Ltd.
    • Spectral Diagnostics Inc./Nanogen
    • Standard Diagnostics, Inc.
    • SureScreen Diagnostics, Ltd.
    • Synova Healthcare, Inc.
    • Talecris Biotherapeutics
    • ThyroTec, Inc.
    • Trinity Biotech plc
    • WaveSense, Inc
    • WayPoint Biomedical, Inc.
    • Xact Aid, Inc.

List of Exhibits

CHAPTER ONE: Executive Summary

  • Figure 1-1: Market Summary: Worldwide Lateral Flow POC Sales 2005-2010

CHAPTER THREE: Technical and Marketing Issues in Lateral Flow Device Commercialization

  • Table 3-1: Selected Innovation in Lateral Flow-Based Tests
  • Table 3-2: Revenues of Leading U.S. Laboratories by Company/Type (Quest, LabCorp, Other Reference Labs, Hospital Labs, Physician Office Labs) 2005
  • Table 3-3: Selected Lateral Flow-Ttype Mixed Systems
  • Table 3-4: Selected Companies Involved in International Marketing Efforts

CHAPTER FOUR: Market Analysis

  • Table 4-1: Worldwide Lateral Flow OTC/Self Test POC Sales by Test Category (Pregnancy/Ovulation, Infectious Disease, Cholesterol, Drugs of Abuse, Other) 2005-2010
  • Table 4-2: Worldwide Lateral Flow Professional POC Sales by Test Category (Pregnancy/Ovulation, Infectious Disease, Cardiac Markers, Cholesterol/Lipids, Drugs of Abuse, Other) 2005-2010
  • Table 4-2: LF POC Test Revenues of Selected IVD Companies 2005
  • Table 4-3: Selected OTC Tests Available, 2005
  • Table 4-4: Selected LF-OTC Test Products 2005
  • Table 4-5: Selected Professional LF Tests on the Market and in Development (Company, Location, Test, Development Status) 2006
  • Table 4-6: HbA1c Test Market by Segment (Lab vs POC): Average Cost per Test, Number of Tests, and Revenues by Region (U.S., Europe, ROW) 2005
  • Table 4-7: Worldwide Sales of Selected Lab Based Cardiac IVDs (Cholesterol/ Lipid Markers, CRP/Inflammation Markers, AMI Enzymes, BNP, Homocysteine, D-Dimer) 2005-2010
  • Table 4-8: Worldwide Sales of OTC POC Cardiac IVDs (Cholesterol/Lipid) 2005-2010
  • Table 4-9: Worldwide Sales of Selected POC Professional Cardiac IVDs (AMI, Cholesterol/Lipids) 2005-2010
  • Table 4-10: Selected LF Infectious Disease Tests (Company, Test, Development/Market Status) 2006
  • Table 4-11: World POC Professional Fecal Occult Blood Test Market by Type (Guaiac vs Immunochemical) 2005-2010
  • Table 4-12: World POC OTC Fecal Occult Blood Test Market by Type (Guaiac, Immuno, Flushable) 2005-2010
  • Table 4-13: Selected OTC Fertility Test Kits Available
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.